Brief: Elevation Oncology Reports Second Quarter 2023 Financial Results
03/08/2023 14:53
Aug 3 (Reuters) - Elevation Oncology Inc ELEV.O :
* ELEVATION ONCOLOGY REPORTS SECOND QUARTER 2023 FINANCIAL
RESULTS
AND HIGHLIGHTS RECENT BUSINESS ACHIEVEMENTS
* ELEVATION ONCOLOGY INC - AS OF JUNE 30, CO HAD CASH, CASH
EQUIVALENTS AND MARKETABLE SECURITIES TOTALING $107.9 MILLION
Source text for Eikon: ID:nPnbhPV4Ha
Further company coverage: ELEV.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Elevation Oncology
See all newsBrief: Elevation Oncology Terminates License Agreement With CSPC Megalith Biopharmaceutical
U.S. RESEARCH ROUNDUP- Crane, Ryder System, Terex
Brief: Elevation Oncology Says Concentra To Buy Elevation Oncology For $0.36 Per Share Plus CVR
Elevation Oncology Inc expected to post a loss of 19 cents a share - Earnings Preview
Brief: Elevation Oncology Inc - To Prepay Term Loan Under Loan & Security Agreement Dated July 27, 2022 - SEC Filing